Miranda Durkie

Miranda first started working in the department in 1996-1998 and re-joined in January 2001 to set up the paediatric molecular oncology service. She is currently Lead Scientist for hereditary cancers, pharmacogenetics, solid tumours and lymphoid disease in the oncology section at Sheffield Diagnostic Genetics Service (SDGS).
She also has a special interest in polycystic kidney disease and is an expert gene reviewer for the Renal Genomics England Clinical Interpretation Partnership (GeCIP).

She organised the Wilson disease external quality assessment (EQA) scheme for the European Molecular Genetics Quality Network (EMQN) for eight years.

Miranda graduated from The University of Sheffield in 1996 with a BSc Honours in Molecular Biology. She worked at SDGS as a research assistant, gaining an MPhil degree in 2000.

After working in Wessex Regional Genetics Laboratory for one year, she returned to Sheffield to obtain her postgraduate certificate in Clinical Molecular Genetics in 2002.

She attained HCPC registration in 2005 and FRCPath part 1 (Molecular Genetics) in 2010. She is currently studying for her FRCPath part 2.